Literature DB >> 34715485

Electroencephalography characteristics to predict one-year outcomes in pediatric anti-NMDA receptor encephalitis.

Jenny Lin1, Kathryn Elkins1, Sonam Bhalla2, Satyanarayana Gedela2, Ammar Kheder2, Guojun Zhang2, Leah Loerinc3, Laura Blackwell4, Robyn Howarth4, Grace Gombolay5.   

Abstract

BACKGROUND: Electrographic characteristics (extreme delta brush, posterior dominant rhythm and slow waves) may predict outcomes in anti-NMDA receptor encephalitis (NMDARE). However, whether changes in EEG sleep architecture predict outcomes are unknown. We examine electrophysiological characteristics including sleep architecture in a pediatric NMDARE population and correlate with outcomes at one year.
METHODS: Retrospective chart and EEG review was performed in pediatric NMDARE patients at a single center. Patients with first EEGs available within 48 h of admission, prior to treatment, and one-year follow-up data were included. EEGs were independently reviewed by two epileptologists, and a third when disagreement occurred. Clinical outcomes included modified Rankin scale (mRS) at one year.
RESULTS: Nine patients (6 females) (range 1.9-16.7 years) were included. Five of nine patients had loss of posterior dominant rhythm (PDR) and three of nine patients had absent sleep architecture. Loss of PDR correlated with a worse mRS score at one year (2.8 versus 0.5, p = 0.038). Loss of PDR and loss of sleep architecture was associated with increased inpatient rehabilitation stay and in higher number of immunotherapy treatments administered. In multivariate analysis, absence of sleep architecture (p = 0.028), absence of PDR (p = 0.041), and epileptiform discharges (p = 0.041) were predictors of mRS at one year.
CONCLUSIONS: Loss of normal PDR, absence of sleep architecture, and epileptiform discharges are associated with worse outcomes at one year which has not been reported before. EEG characteristics may help prognosticate in NMDARE. Larger studies are needed to confirm these findings.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-NMDA receptor encephalitis; Delta brush; EEG; Electroencephalography; Pediatric; Sleep

Mesh:

Substances:

Year:  2021        PMID: 34715485      PMCID: PMC9051600          DOI: 10.1016/j.eplepsyres.2021.106787

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   2.991


  19 in total

1.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

2.  Predictive value of electroencephalography in anti-NMDA receptor encephalitis.

Authors:  Agnes van Sonderen; Samuel Arends; Dénes L J Tavy; Anna E M Bastiaansen; Marienke A A M de Bruijn; Marco W J Schreurs; Peter A E Sillevis Smitt; Maarten J Titulaer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-08-22       Impact factor: 10.154

3.  The clinical meaning of Rankin 'handicap' grades after stroke.

Authors:  R de Haan; M Limburg; P Bossuyt; J van der Meulen; N Aaronson
Journal:  Stroke       Date:  1995-11       Impact factor: 7.914

4.  Longitudinal electroencephalographic (EEG) findings in pediatric anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis: the Padua experience.

Authors:  Margherita Nosadini; Clementina Boniver; Luigi Zuliani; Luca de Palma; Elisa Cainelli; Pier Antonio Battistella; Irene Toldo; Agnese Suppiej; Stefano Sartori
Journal:  J Child Neurol       Date:  2014-01-05       Impact factor: 1.987

5.  Epileptic phenotypes, electroclinical features and clinical characteristics in 17 children with anti-NMDAR encephalitis.

Authors:  E Haberlandt; M Ensslen; U Gruber-Sedlmayr; B Plecko; M Brunner-Krainz; M Schimmel; S Schubert-Bast; U Neirich; H Philippi; G Kurleman; M Tardieu; G Wohlrab; I Borggraefe; K Rostásy
Journal:  Eur J Paediatr Neurol       Date:  2016-12-05       Impact factor: 3.140

6.  Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.

Authors:  Josep Dalmau; Erdem Tüzün; Hai-yan Wu; Jaime Masjuan; Jeffrey E Rossi; Alfredo Voloschin; Joachim M Baehring; Haruo Shimazaki; Reiji Koide; Dale King; Warren Mason; Lauren H Sansing; Marc A Dichter; Myrna R Rosenfeld; David R Lynch
Journal:  Ann Neurol       Date:  2007-01       Impact factor: 10.422

7.  NMDA Receptor-mediated Ca2+ Influx in the Absence of Mg2+ Block Disrupts Rest: Activity Rhythms in Drosophila.

Authors:  Qian Song; Ge Feng; Jiaxing Zhang; Xuechun Xia; Min Ji; Lei Lv; Yong Ping
Journal:  Sleep       Date:  2017-12-01       Impact factor: 5.849

8.  Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis.

Authors:  Marienke A A M de Bruijn; Femke K Aarsen; Marielle P van Oosterhout; Marieke M van der Knoop; Coriene E Catsman-Berrevoets; Marco W J Schreurs; Danielle E M Bastiaansen; Peter A E Sillevis Smitt; Rinze F Neuteboom; Maarten J Titulaer
Journal:  Neurology       Date:  2018-04-27       Impact factor: 9.910

9.  Mouse model of anti-NMDA receptor post-herpes simplex encephalitis.

Authors:  Jenny Linnoila; Benjamin Pulli; Thaís Armangué; Jesús Planagumà; Radha Narsimhan; Stefan Schob; Matthias W G Zeller; Josep Dalmau; John Chen
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.